Land: Canada
Språk: engelsk
Kilde: Health Canada
ROSIGLITAZONE (ROSIGLITAZONE MALEATE)
PHARMASCIENCE INC
A10BG02
ROSIGLITAZONE
2MG
TABLET
ROSIGLITAZONE (ROSIGLITAZONE MALEATE) 2MG
ORAL
100
Prescription
THIAZOLIDINEDIONES
Active ingredient group (AIG) number: 0138802002; AHFS:
CANCELLED PRE MARKET
2017-08-03
PRODUCT MONOGRAPH PR PMS-ROSIGLITAZONE Rosiglitazone (as Rosiglitazone Maleate) 2 mg, 4 mg and 8 mg Tablets Professed Standard Antidiabetic Agent Insulin Resistance Reducing Agent PHARMASCIENCE INC. 6111 Royalmount Ave., Suite 100 Montreal, Quebec H4P 2T4 www.pharmascience.com DATE OF REVISION: June 20, 2016 _ _ Submission Control No: 195686_ _ _ _ _ _ _pms-ROSIGLITAZONE Product Monograph _ _Page 2 of 53_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ....................................................................................... 3 SUMMARY PRODUCT INFORMATION .............................................................................................................. 3 INDICATIONS AND CLINICAL USE .................................................................................................................... 3 CONTRAINDICATIONS ......................................................................................................................................... 4 WARNINGS AND PRECAUTIONS ........................................................................................................................ 4 ADVERSE REACTIONS ....................................................................................................................................... 10 DRUG INTERACTIONS ........................................................................................................................................ 15 DOSAGE AND ADMINISTRATION .................................................................................................................... 18 OVERDOSAGE ...................................................................................................................................................... 19 ACTION AND CLINICAL PHARMACOLOGY .................................................................................................. 19 STORAGE AND STABILITY ................................................................................................................. read_full_document